OPPILAN PHARMA LTD has a total of 15 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CHENGDU DIAO PHARMACEUTICAL GR, ALTER LAB and MITHRIDION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Mohan Raju | 12 |
#2 | Harris Jason | 11 |
#3 | Nuss John | 11 |
#4 | John Nuss | 2 |
#5 | Raju Mohan | 2 |
#6 | Jason Harris | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018211323A1 | Heterocyclic compounds for the treatment of disease | |
WO2018211324A1 | Prodrugs for the treatment of disease | |
CA3005236A1 | Heterocyclic compounds for the treatment of disease |